Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma - Wikidata - wikimedia - TriplyDB

Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma

Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma

http://www.wikidata.org/entity/Q36115650

about

Complexities of TGF-β targeted cancer therapy.Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer.Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.Role of TGF-beta 1 and TGF-beta type II receptor in gastric cancer.Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer.Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis.Exploring anti-TGF-β therapies in cancer and fibrosis.Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model.Development of a novel multiplexed assay for quantification of transforming growth factor-β (TGF-β).Expression of Cytokines Interleukin-2, Interleukin-4, Interleukin-10 and Transforming Growth Factor β in Gastric Adenocarcinoma Biopsies Obtained from Mexican Patients Association between the TGFB1 -509C/T and TGFBR2 -875A/G polymorphisms and gastric cancer: a case-control study Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.Polymorphisms in the potential functional regions of the TGF-β 1 and TGF-β receptor genes and disease susceptibility in HBV-related hepatocellular carcinoma patients.

P2860

Q27693607-B69817A3-B70E-4771-8601-39D9CD1C1CE3 Q33813425-15503E02-5672-4591-8847-C8169E49B9D4 Q35093612-46D48A31-0132-498C-A230-FB33D008D984 Q35937392-17E0DFB4-A770-4A5D-A398-C28805F40457 Q36610882-5CD2C508-5881-4479-A889-C2CF6FAF81B0 Q36620899-0F709793-C9D0-40B5-BF4A-0FBC364F5F64 Q36944020-BE5692B9-C4D6-4DA5-B20F-232162884613 Q37896073-65F5CF2A-7F83-4704-BF44-73CFD181648F Q38348547-4D2373D4-378B-4309-8E1A-1BDCAF81FD71 Q38920213-CE264F3B-D648-4ACB-8C53-7F56CA95F207 Q41813201-DC138A74-231E-4405-9F97-C04FC2458188 Q42259485-ABA23F26-4852-4AED-8C66-A5FD893A9E43 Q43904336-B35518A8-3FAB-4154-844B-899F4168C36C Q54533115-1F1A600F-67E0-4F91-AFC1-99AC6F00E40B

P2860

Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma

http://www.wikidata.org/entity/Q36115650

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Transforming growth factor bet ...... in advanced gastric carcinoma

@ast

Transforming growth factor bet ...... in advanced gastric carcinoma

@en

type

label

Transforming growth factor bet ...... in advanced gastric carcinoma

@ast

Transforming growth factor bet ...... in advanced gastric carcinoma

@en

prefLabel

Transforming growth factor bet ...... in advanced gastric carcinoma

@ast

Transforming growth factor bet ...... in advanced gastric carcinoma

@en

P1433

Q36115650-0A74F9D8-F06C-4E9D-9C4B-5D5A38F158BA

P1476

Q36115650-C0C96FBB-464E-45AE-BE51-65997F7E2900

P2093

Q36115650-280D600F-84B8-4E45-B7B8-77B37D8DEC5B

Q36115650-3843B41D-237B-4E68-9B5F-8CFA66DE239C

Q36115650-5BA78BBB-E6D7-493A-826E-E565F62F54A9

Q36115650-7A80B455-B9F0-46FF-9C6A-B6C6A8683849

Q36115650-919CAE6E-D2C1-41C9-88A2-F9538CC1D7F8

Q36115650-ADCCEA72-448B-41F7-BB8D-AD97C68E5189

Q36115650-E3582661-5978-4273-8E05-03E868A5AF57

P2860

Q36115650-0056B2B0-FE5F-4F4D-BD88-3128598F0585

Q36115650-106EA574-48A6-49B4-BE71-53FB203A621B

Q36115650-13236789-E256-42CF-B14E-3BCF6B3947EC

Q36115650-196316CB-1A1C-415E-82CE-B9051D92895D

Q36115650-2E5ECBC6-D262-4C6C-BE8B-E97BBB0A7E4A

Q36115650-2FADB6E5-DEB5-4B70-A28E-77DADFE9106C

Q36115650-3579F180-247E-47EC-92E6-D77657AF56C4

Q36115650-3A9BAB87-090B-4EC6-9901-E8C4640EA727

Q36115650-424CE9BA-318F-42B5-AE8F-545EFB727AB6

Q36115650-4FEDCA1A-F4DF-4FBD-B8F8-59060E37A60E

P2888

Q36115650-4F2128CB-981D-4FD7-AEE5-2C7A3B1D200C

P304

Q36115650-2C5466DA-DD75-4F6D-B07E-E37FDC47F456

P31

Q36115650-64D7DDC6-11C1-439D-80E3-F51622976177

P356

Q36115650-660E1DC6-7341-476F-AEE6-02D95CF3EC2F

P407

Q36115650-D7B8F976-9F4D-4EAA-A3D1-D6A04C379584

P433

Q36115650-B46E0D34-A300-4641-9A9C-FBD1CCEC2E0D

P478

Q36115650-F438A3A7-0697-40C8-80EB-C2BE9B61CDBB

P577

Q36115650-0EED14FE-E575-4B62-9AF2-840FD3C4D5CD

P5875

Q36115650-1618B6D0-15D5-48AA-AA2B-BDA29848FC71

P698

Q36115650-470D8C3F-2433-42B9-B6B9-03BEA394D6CA

P932

Q36115650-AF6BF882-C1D3-4A6C-88C3-525057B568D8

P356

P1433

British Journal of Cancer

P1476

Transforming growth factor bet ...... in advanced gastric carcinoma

@en

P2093

Fujimoto K

http://www.w3.org/2001/XMLSchema#string

Katano M

http://www.w3.org/2001/XMLSchema#string

Kuwahara A

http://www.w3.org/2001/XMLSchema#string

Miyazaki K

http://www.w3.org/2001/XMLSchema#string

Mori M

http://www.w3.org/2001/XMLSchema#string

Morisaki T

http://www.w3.org/2001/XMLSchema#string

Nakamura M

http://www.w3.org/2001/XMLSchema#string

P2860

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential

Lymph node metastases of gastric cancer. General pattern in 1931 patients.

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.

Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.

Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.

P2888

P304

1373-1378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1998.687

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253934475

http://www.w3.org/2001/XMLSchema#string

P698

9823982

http://www.w3.org/2001/XMLSchema#string

P932

2063172

http://www.w3.org/2001/XMLSchema#string